Listen to the article
President Trump has nominated Dr. Erica Schwartz to lead the Centers for Disease Control and Prevention, marking a significant leadership change at one of the nation’s premier public health institutions.
The announcement came Thursday via a post on Truth Social, where Trump described Dr. Schwartz as “incredibly talented” and praised her impressive credentials. Schwartz holds degrees from Brown University for both her undergraduate studies and medical education, along with a law degree and a master’s in public health.
“Erica graduated from Brown University for College and Medical School, and served a distinguished career as a Doctor of Medicine in the United States Military,” Trump wrote. “She is a STAR!”
Schwartz previously served as Deputy Surgeon General during Trump’s first administration, continuing briefly into the Biden presidency. Her extensive background includes military medical service and, most recently, a position on the board of directors at Butterfly Network Inc., a medical imaging technology company.
Health and Human Services Secretary Robert F. Kennedy Jr. expressed support for the nomination on social media, stating he looks forward to working with Schwartz to “restore trust, accountability, and scientific integrity at the CDC” and “Make America Healthy Again,” echoing a campaign slogan that has become central to the administration’s health policy messaging.
Trump’s announcement outlined a complete leadership restructuring at the CDC, with several additional appointments. Sean Slovenski has been tapped as CDC Deputy Director and Chief Operating Officer, Dr. Jennifer Shuford as Deputy Director and Chief Medical Officer, and Dr. Sara Brenner as Senior Counselor for Public Health to Secretary Kennedy.
The nomination comes at a critical time for the CDC, which faces the task of rebuilding public trust after criticism during the COVID-19 pandemic. Under the Biden administration, the agency weathered significant challenges regarding its pandemic response, communication strategies, and policy implementation.
Republican lawmakers have already begun voicing support for the nomination. Senator Tommy Tuberville of Alabama described Dr. Schwartz as a promising choice, saying, “Under Joe Biden, the CDC was a disaster. I have no doubt that Dr. Schwartz will ensure the CDC is 100% focused on making Americans HEALTHY again.”
The CDC, headquartered in Atlanta, Georgia, operates with an annual budget of approximately $8.3 billion and employs over 10,000 people across the United States and globally. As the nation’s health protection agency, it plays a crucial role in disease prevention, health promotion, and responding to public health threats both domestically and internationally.
Before taking office, Schwartz must secure Senate confirmation, a process that could face scrutiny given the politically charged nature of public health policy in recent years. Her confirmation hearings are likely to address her vision for the agency, approach to emerging health threats, and strategies for addressing longstanding public health challenges.
Public health experts are watching the nomination closely, as the CDC continues to monitor several ongoing health concerns, including antibiotic resistance, emerging infectious diseases, and chronic disease prevention.
Trump’s statement emphasized a shift in focus from the previous administration, suggesting his new appointees would steer away from mandate-focused policies. “These Highly Respected Doctors of Medicine have the knowledge, experience, and TOP degrees to restore the GOLD STANDARD OF SCIENCE at the CDC,” Trump stated, adding they would do a “TREMENDOUS job leading the CDC as we continue to MAKE AMERICA HEALTHY AND GREAT AGAIN!”
The nomination represents the latest in a series of key appointments as the Trump administration continues to fill critical positions across federal agencies.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.


4 Comments
This is a surprising pick given Dr. Schwartz’s ties to the previous administration. I wonder how her leadership will impact the CDC’s pandemic response and other public health priorities. It will be important to monitor her actions and decisions closely.
While Dr. Schwartz’s credentials seem impressive, I have some concerns about the political nature of this nomination. The CDC should remain a non-partisan, science-based institution. I hope she can maintain its independence and focus on public health above all else.
Dr. Schwartz’s experience in the military and in the medical field could be valuable assets at the CDC. However, I’m skeptical of politically-motivated leadership changes at such a critical public health agency. Hopefully she can earn the trust of the scientific community.
This is an interesting choice to lead the CDC. Dr. Schwartz’s background in military medicine and public health could bring a fresh perspective. I’m curious to learn more about her vision and priorities for the agency.